A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2006
10/19/2006	CA2605253A1 Selective modulation of tumour necrosis factor receptors in therapy
10/19/2006	CA2604683A1 Method of inducing neutralizing antibodies to human immunodeficiency virus
10/19/2006	CA2604542A1 Composition for treating cancer adapted for intra-tumoral administration and uses thereof
10/19/2006	CA2604538A1 Hiv vaccine
10/19/2006	CA2604443A1 Use of anti-ngf antibody for improving stiffness in osteoarthritis
10/19/2006	CA2604363A1 Multivalent pneumococcal polysaccharide-protein conjugate composition
10/19/2006	CA2604362A1 Separation of contaminants from streptococcus pneumoniae polysaccharide by ph manipulation
10/19/2006	CA2604330A1 Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
10/19/2006	CA2604242A1 Immunomodulating compositions and uses therefor
10/19/2006	CA2604036A1 Cathepsin s antibody
10/19/2006	CA2603940A1 Antibodies against mammalian metapneumovirus
10/19/2006	CA2603863A1 Gammaretrovirus associated with cancer
10/19/2006	CA2603847A1 Conjugated anti-psma antibodies
10/19/2006	CA2603780A1 Sema4d in cancer diagnosis, detection and treatment
10/19/2006	CA2603264A1 Antibody substituting for function of blood coagulation factor viii
10/19/2006	CA2600709A1 Use of cd25 antibodies in immunotherapy
10/19/2006	CA2598578A1 Antitumor combination comprising substituted acryloyl distamycin derivatives and antibodies inhibiting growth factors or their receptors
10/19/2006	CA2595276A1 Anti-interferon gamma antibodies and methods of use thereof
10/18/2006	EP1712628A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/18/2006	EP1712620A1 Peptide originating in epidermal growth factor receptor (egfr)
10/18/2006	EP1712619A1 Preventive/remedy for cancer
10/18/2006	EP1712566A1 Inflammatory cytokine inhibitor
10/18/2006	EP1712565A1 Cell death inducing agents
10/18/2006	EP1712243A1 Gene therapy for tumor using minus-strand rna viral vectors encoding immunostimulatory cytokines
10/18/2006	EP1712241A1 Composition for treating cancer adapted for intra-tumoral administration and uses thereof
10/18/2006	EP1712240A1 Stable water-based medicinal preparation containing antibody
10/18/2006	EP1712239A2 Interleukin-1 inhibitors in the treatment of diseases
10/18/2006	EP1712238A1 Anthracyclin induced immunogenic dead or dying cells composition
10/18/2006	EP1712234A1 Use of 4-Pyridylmethylphthalazines for Cancer Treatment
10/18/2006	EP1711619A2 Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof
10/18/2006	EP1711609A1 Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them
10/18/2006	EP1711531A2 Neutralizing antibodies and methods of use thereof
10/18/2006	EP1711528A2 Treatment of cancer with novel anti-il 13 monoclonal antibodies
10/18/2006	EP1711527A2 Hla-dr-specific antibodies, compositions and methods
10/18/2006	EP1711518A2 Chimpanzee adenovirus vaccine carriers
10/18/2006	EP1711509A2 Inhibition of bright function as a treatment for excessive immunoglobulin production
10/18/2006	EP1711208A2 Conjugates of amyloid proteins as vaccines for amyloid-related diseases
10/18/2006	EP1711207A2 Interferon alpha antibodies and their uses
10/18/2006	EP1711206A2 Compositions and methods of use of w-peptides
10/18/2006	EP1711205A1 Synergistic liposomal adjuvants
10/18/2006	EP1711204A1 Monoparaimmunity inducers based on attenuated rabbit myxoma viruses
10/18/2006	EP1711203A1 Targeted atherosclerosis treatment
10/18/2006	EP1711196A2 Inhibitors of type 2 vascular endothelial growth factor receptors
10/18/2006	EP1711176A1 Immunomodulatory alkaloids
10/18/2006	EP1711174A1 Adjuvant compositions
10/18/2006	EP1407006B9 Method for the recovery and purification of poxviruses from infected cells
10/18/2006	EP1358332B1 A serpin in bifidobacteria
10/18/2006	EP1165778B1 Uses of casb618 polynucleotides and polypeptides
10/18/2006	EP1155119B1 Bhv-1 gene-deleted virus vaccine
10/18/2006	EP1141286B1 Cytokine receptor chain
10/18/2006	EP0969862B1 Synthetic hiv gag genes
10/18/2006	EP0944649B1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
10/18/2006	EP0927252B1 Antibodies against interferon alpha/beta receptor
10/18/2006	EP0914156B1 Passively administered antibody that enhances feed conversion efficiency
10/18/2006	EP0797664B1 Use of a human interleukin-11 receptor
10/18/2006	EP0778849B1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
10/18/2006	EP0656788B1 Hla binding peptides and their uses
10/18/2006	CN1849395A HLA-a24 binding cancer antigen peptide derived from ribin
10/18/2006	CN1849339A 治疗性结合分子 Therapeutic binding molecules
10/18/2006	CN1849337A Compositions and methods for treating cancer using IGSF9 and LIV-1
10/18/2006	CN1849334A Lawsonia intracellularis subunit vaccine
10/18/2006	CN1849139A Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
10/18/2006	CN1849138A Human anti-NGF neutralizing antibodies as selective ngf pathway inhibitors
10/18/2006	CN1849137A Special reagent for diagnosing and treating disease based on VEFG,HER-2,PSA protein isomer
10/18/2006	CN1849136A Cancerous disease modifying antibodies
10/18/2006	CN1849135A Methods for treating interleukin-6-related diseases
10/18/2006	CN1849134A Functional influenza virus-like particles(VLPs)
10/18/2006	CN1849131A Treating immunological disorders using agonists of interleukin-21 / interleukin-21 receptor
10/18/2006	CN1849122A Method of treating cancer using fpt inhibitors and at least two antineoplastic agents
10/18/2006	CN1847397A EHEC 0157 shiga-like toxin IIA resisting subunit monoclonal antibody 5F3 light and heavy chain variable region gene and its application
10/18/2006	CN1847392A Process of producing gene engineering subunit vaccine of chicken's infectious bursal disease with colibacillus
10/18/2006	CN1846786A Vaccins vivants recombines et adjuves
10/18/2006	CN1280414C Human antibody heavy chain and light chain variable region gene against SARS-Cov S antigen and polypeptide and use thereof
10/18/2006	CN1280410C Cholera vibrio strain
10/18/2006	CN1280310C Fusion protein with cold proventing and curing function and its encoding gene and use
10/18/2006	CN1279979C Nucleic vaccine for tubercle bacillus
10/18/2006	CN1279978C Purification method of dermatonecrotoxin and anatoxin produced by Bordetella
10/18/2006	CN1279977C Peptide-based fluorescence polarization assay for detection of antibodies to mycobacterium bovis
10/18/2006	CN1279976C Adjuvant for transcutaneous immunization
10/18/2006	CN1279971C Novel method for down-regulation of amyloid
10/17/2006	US7122654 Hybrid; adjust vascular system permeability
10/17/2006	US7122652 Isolated polynucleotide encoding a variant human pregnane X receptor (hPXR) polypeptide or fragment; detection and genotyping of hPXR alleles in humans, homozygous as well as heterozygous, alleles of the hPXR gene
10/17/2006	US7122641 Methods for purifying protein
10/17/2006	US7122638 Hybridomas cell lines; viricides
10/17/2006	US7122637 Polypeptide variants with altered effector function
10/17/2006	US7122635 Method and composition for angiogenesis inhibition
10/17/2006	US7122631 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/17/2006	US7122577 Use of mycolic acids possessing immunoregulatory and immunogenic properties in the prophylaxis and/or therapy of diseases, particularly those induced by or associated with Mycobacteria
10/17/2006	US7122374 For immunotherapy for the treatment of diseases, e.g., neurodegenerative diseases
10/17/2006	US7122372 Peptide useful in immunomodulation
10/17/2006	US7122370 Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
10/17/2006	US7122360 Polypeptides, polynucleotides and uses thereof
10/17/2006	US7122347 A chimeric Arterivirus composed of parts originating from at least two different arteriviruses where a stretch of nucleic acids encoding a non-Arteriviris protein fragment is inserted in the full genome; vaccines; veterinary medicine; swine
10/17/2006	US7122311 Diagnosing respiratory disorder; obtain cells, monitor expression of marker gene, determine sequence, compare to control, detect polymorphism in polypeptide or nucleotide, presence of polymorphism indicates respiratory disorders
10/17/2006	US7122306 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
10/17/2006	US7122302 Method for determining early HCV seroconversion
10/17/2006	US7122197 Compounds from Moraxella catarrhalis
10/17/2006	US7122196 Compounds and methods for diagnosis of tuberculosis
10/17/2006	US7122195 Mutant mycobacteria for use in therapy
10/17/2006	US7122194 Mixture of polypeptide with carrier

1 ... 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 ... 1823